Former CFO · Beam Therapeutics Inc. (BEAM)

Terry-Ann Burrell

A named executive officer of Beam Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,768,161

Salary $321,910Stock awards $1,175,850

FY2023: $2,557,844

4th of 6 named executive officers at Beam Therapeutics by FY2024 total.

6 named officers on file for Beam Therapeutics, FY2024

Terry-Ann Burrell’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 10 equity grants, each cited to its filing
  • BEAM’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Beam Therapeutics’s whole pay program stands against its peers

  • Beam Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BEAM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2025 (DEF 14A).

Free

Get Terry-Ann Burrell’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Terry-Ann Burrell compensation by year

Beam Therapeutics Summary Compensation Table · all 6 fiscal years held
In US dollars, as Beam Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023FY2024
Salary$147,180$420,000$441,000$480,000$505,000$321,910
Bonus$0$0$0$0$0$0
Stock awards$0$0$1,400,700$859,500$612,400$1,175,850
Option awards$3,901,485$0$1,850,681$1,376,880$1,217,244$1,259,301
Non-equity incentive$200,000$210,000$229,320$220,800$212,100$0
Pension and deferred compensation$0$0$0$0$0$0
All other$54,058$53,752$17,203$10,350$11,100$11,100
Total$4,302,723$683,752$3,938,904$2,947,530$2,557,844$2,768,161

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Beam Therapeutics Inc. DEF 14A filed April 18, 2025, accession 0000950170-25-055853, and prior-year filings.

How this page was built: the Beam Therapeutics Inc. filed document, accession 0000950170-25-055853. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2025.

$4.3M
$684K
$3.9M
$2.9M
$2.6M
$2.8M
FY19
FY20
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU20,000$544,400—
RSU11,250$306,225—
RSU8,750$238,175—
Option10,938—$80.04
Option15,625—$69.21
Option30,834—$43.45

Per the Outstanding Equity Awards at Fiscal Year-End table in Beam Therapeutics Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Beam Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
John EvansCEO$6,409,631
Sravan EmanyChief Financial Officer$4,818,306
Giuseppe CiaramellaPresident$3,378,647
Terry-Ann Burrell · this pageFormer CFO$2,768,161
Amy SimonCMO$2,615,681
Christine BellonCLO$2,581,460

The full Beam Therapeutics compensation record

free company brief

This page is one person within Beam Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Beam Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Terry-Ann Burrell's compensation dossier · One-time report. No refunds.